Free Trial

Meritage Portfolio Management Sells 30,545 Shares of MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

Meritage Portfolio Management lessened its position in MetLife, Inc. (NYSE:MET - Free Report) by 89.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,727 shares of the financial services provider's stock after selling 30,545 shares during the period. Meritage Portfolio Management's holdings in MetLife were worth $307,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in MET. Vanguard Group Inc. grew its holdings in MetLife by 3.4% in the 1st quarter. Vanguard Group Inc. now owns 59,622,348 shares of the financial services provider's stock worth $4,418,612,000 after acquiring an additional 1,974,268 shares during the last quarter. Swedbank AB purchased a new position in MetLife during the 1st quarter valued at about $131,456,000. Acadian Asset Management LLC lifted its position in MetLife by 7,837.0% during the 2nd quarter. Acadian Asset Management LLC now owns 1,129,353 shares of the financial services provider's stock valued at $79,250,000 after acquiring an additional 1,115,124 shares during the period. Dimensional Fund Advisors LP lifted its position in MetLife by 22.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider's stock valued at $378,799,000 after acquiring an additional 988,666 shares during the period. Finally, Bessemer Group Inc. lifted its position in MetLife by 29.7% during the 1st quarter. Bessemer Group Inc. now owns 2,120,275 shares of the financial services provider's stock valued at $157,133,000 after acquiring an additional 485,811 shares during the period. Institutional investors own 89.81% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on MET shares. Wells Fargo & Company lifted their target price on shares of MetLife from $92.00 to $93.00 and gave the stock an "overweight" rating in a report on Tuesday, November 5th. StockNews.com cut shares of MetLife from a "buy" rating to a "hold" rating in a report on Friday, October 4th. Jefferies Financial Group lifted their target price on shares of MetLife from $89.00 to $95.00 and gave the stock a "buy" rating in a report on Friday, September 27th. Piper Sandler lifted their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 2nd. Finally, Morgan Stanley reduced their price target on shares of MetLife from $86.00 to $85.00 and set an "overweight" rating for the company in a research note on Monday, August 19th. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, MetLife currently has an average rating of "Moderate Buy" and a consensus target price of $88.46.

Check Out Our Latest Stock Analysis on MET

MetLife Price Performance

Shares of MET traded up $0.18 during mid-day trading on Tuesday, reaching $81.95. The stock had a trading volume of 867,838 shares, compared to its average volume of 3,325,696. The firm has a market cap of $56.74 billion, a price-to-earnings ratio of 16.49, a PEG ratio of 0.74 and a beta of 1.05. MetLife, Inc. has a 12 month low of $60.26 and a 12 month high of $86.94. The business has a fifty day moving average of $81.12 and a 200 day moving average of $75.30. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be paid a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.66%. The ex-dividend date is Tuesday, November 5th. MetLife's payout ratio is 43.95%.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should you invest $1,000 in MetLife right now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines